Back
35· Cooling
Markets1h 44m ago
Indian pharmaceutical companies are shifting focus from generics to biosimilars, capitalizing on upcoming patent expiries of blockbuster biologics for global growth and higher profitability.
Archive Window: 7 Days Left
India
Who
Indian pharmaceutical companies
What
Indian pharmaceutical companies are shifting focus from generics to biosimilars, capitalizing on upcoming patent expiries of blockbuster biologics for global growth and higher profitability.
When
Tue, 14 Jul 2026 23:34:00 GMT · 1h 44m ago
Where
India ·
Why
Upcoming patent expiries of blockbuster biologics present an opportunity for higher profitability and global growth in the biosimilars market.
The Frontline Impact
How this affects you
This strategic shift by Indian pharmaceutical companies into biosimilars could lead to increased global market share and higher profit margins for the sector.
Story chain
1 event in this threadNo related history yet - this is the origin event.